FDA-Drug2018-12-19Class II
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31
Dr. Reddy's Laboratories, Inc.
Hazard
Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.
Sold states
Product was distributed to 4 major distributors who distributed the product throughout the United States.
Affected count
4,404 (30 count blister packs)
Manufactured in
107 College Rd E, N/A, Princeton, NJ, United States
Products
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0294-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief